News

The collaboration will leverage Synageva’s product development capabilities and proprietary protein expression platform. As per the agreement, Mitsubishi will make an upfront payment of $9m and Synageva will

As per the agreement, AstraZeneca will pay $50m to Amgen and both the companies will share costs and profits. Based on present plan, approximately 65% of costs for

Under the agreement, Ajinomoto gains exclusive rights to elobixibat and in return the company will pay pay a significant upfront fee, milestones and tiered double-digit royalties to Albireo.

The Quidel Molecular Direct C difficile Tox A/B assay kits consist of an extraction-free, three-step sample preparation process that requires no heat step, no timed step, and no

The product is the generic equivalent to Baxter Healthcare’s Mesnex Injection. Mylan has begun shipping the generic drug, which has been approved by the US Food and Drug

Ingenuity iReport for Real-Time PCR provides a rapid and comprehensive understanding of pathways, processes, and diseases relevant to gene expression results. The new solution is an interactive report

AggregateSpend360 will support local, country-specific and global transparency and reporting requirements. The service, available in Software as a Service (SaaS) and licensed models, collects all necessary compliance data

The three patients of cohort 2 received a dose of 1×10(9) colony forming units (cfu)/day for up to 28 days of continuous oral dosing. Dosing of third cohort

Irbesartan and Irbesartan-Hydrochlorothiazide tablets are generic equivalents to Sanofi Aventis’ high blood pressure treatments, Avapro and Avalide tablets. Teva has been granted a 180-day period of marketing exclusivity,